Key result
Non-coding RNAs in small extracellular vesicles are closely associated with diabetic cardiomyopathy and may act as potential diagnostic and therapeutic targets.
Why the study?
Diabetic cardiomyopathy is a leading cause of mortality in patients with diabetes, but its underlying pathogenesis has not been fully elucidated.
This review highlights the potential of targeting non-coding RNAs in small extracellular vesicles as a diagnostic and therapeutic strategy for diabetic cardiomyopathy.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for ncRNA biomarkers in diabetic cardiomyopathy; prospective validation required before clinical use.
Diabetic cardiomyopathy (DCM) is defined as abnormalities in myocardial structure and function in the setting of diabetes and in the absence of cardiovascular diseases, such as coronary artery disease, hypertension, and valvular heart disease. DCM is one of the leading causes of mortality in patients with diabetes. However, the underlying pathogenesis of DCM has not been fully elucidated. Recent studies have revealed that non-coding RNAs (ncRNAs) in small extracellular vesicles (sEVs) are closely associated with DCM and may act as potential diagnostic and therapeutic targets. Here, we introduced the role of sEV-ncRNAs in DCM, summarized the current therapeutic advancements and limitations of sEV-related ncRNAs against DCM, and discussed their potential improvement.
No takes yet. Share an insight, caveat, or question.
Ding et al. (2023) conducted a review in Diabetic cardiomyopathy. Non-coding RNAs in small extracellular vesicles (sEV-ncRNAs) was evaluated. Non-coding RNAs in small extracellular vesicles are closely associated with diabetic cardiomyopathy and may act as potential diagnostic and therapeutic targets.
Synapse has enriched 10 related papers. Consider them for comparative context: